These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35495887)

  • 41. The Negative Predictive Value of a PI-RADS Version 2 Score of 1 on Prostate MRI and the Factors Associated With a False-Negative MRI Study.
    Ma HY; Ahmed FS; Luk L; Martina LAP; Wenske S; Shaish H
    AJR Am J Roentgenol; 2020 Sep; 215(3):667-672. PubMed ID: 32755155
    [No Abstract]   [Full Text] [Related]  

  • 42. Fetal growth, fetal development, and placental features in women with polycystic ovary syndrome: analysis based on fetal and placental magnetic resonance imaging.
    Zhang Q; Bao ZK; Deng MX; Xu Q; Ding DD; Pan MM; Xi X; Wang FF; Zou Y; Qu F
    J Zhejiang Univ Sci B; 2020 Dec.; 21(12):977-989. PubMed ID: 33843163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of placental volume and vascular flow indices as predictors of intrauterine growth retardation.
    González-González NL; González-Dávila E; González Marrero L; Padrón E; Conde JR; Plasencia W
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():13-19. PubMed ID: 28327375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of specific MRI features in the evaluation of suspected placental invasion.
    Lax A; Prince MR; Mennitt KW; Schwebach JR; Budorick NE
    Magn Reson Imaging; 2007 Jan; 25(1):87-93. PubMed ID: 17222719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of magnetic resonance imaging in the diagnosis of placenta accreta.
    Niu L; Cui W; Zhu C; Lu X; Wang Y; Wang F
    Curr Med Imaging; 2023 Jun; ():. PubMed ID: 37366359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome.
    Delli Pizzi A; Tavoletta A; Narciso R; Mastrodicasa D; Trebeschi S; Celentano C; Mastracchio J; Cianci R; Seccia B; Marrone L; Liberati M; Cotroneo AR; Caulo M; Basilico R
    Abdom Radiol (NY); 2019 May; 44(5):1873-1882. PubMed ID: 30600374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of placenta accreta spectrum by a scoring system based on maternal characteristics combined with ultrasonographic features.
    Gao Y; Gao X; Cai J; Han F; Xu G; Zhang X; Zhang T; Yu L
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1011-1017. PubMed ID: 34794730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: A retrospective study with external validation.
    Maurea S; Verde F; Romeo V; Stanzione A; Mainenti PP; Raia G; Barbuto L; Iacobellis F; Santangelo F; Sarno L; Migliorini S; Petretta M; D'Armiento M; De Dominicis G; Santangelo C; Guida M; Romano L; Brunetti A
    Eur J Radiol; 2023 Nov; 168():111116. PubMed ID: 37801998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal Changes in Placental Magnetic Resonance Imaging Relaxation Parameter in Murine Pregnancy: Compartmental Analysis.
    Krishnamurthy U; Szalai G; Shen Y; Xu Z; Yadav BK; Tarca AL; Chaiworapongsa T; Hernandez-Andrade E; Than NG; Haacke EM; Romero R; Neelavalli J
    Gynecol Obstet Invest; 2016; 81(3):193-201. PubMed ID: 26336923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRI features of the placenta in fetuses with and without CNS abnormalities.
    Shapira-Zaltsberg G; Grynspan D; Quintana MV; Dominguez PC; Reddy D; Davila JH; Miller E
    Clin Radiol; 2018 Sep; 73(9):836.e9-836.e15. PubMed ID: 29895388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Application of magnetic resonance imaging to predict the type and severity of placenta accreta].
    Li L; Zhao YY; Wang Y; Yan S; Yang J; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(31):2431-2434. PubMed ID: 28835043
    [No Abstract]   [Full Text] [Related]  

  • 53. Prediction for Postpartum Hemorrhage of Placenta Previa Patients through MRI Using Self-Adaptive Edge Detection Algorithm.
    Chen Y; Xu T
    Contrast Media Mol Imaging; 2021; 2021():8343002. PubMed ID: 34526873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental MRI in intrauterine fetal growth restriction.
    Damodaram M; Story L; Eixarch E; Patel A; McGuinness A; Allsop J; Wyatt-Ashmead J; Kumar S; Rutherford M
    Placenta; 2010 Jun; 31(6):491-8. PubMed ID: 20347139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The hemodynamics of late-onset intrauterine growth restriction by MRI.
    Zhu MY; Milligan N; Keating S; Windrim R; Keunen J; Thakur V; Ohman A; Portnoy S; Sled JG; Kelly E; Yoo SJ; Gross-Wortmann L; Jaeggi E; Macgowan CK; Kingdom JC; Seed M
    Am J Obstet Gynecol; 2016 Mar; 214(3):367.e1-367.e17. PubMed ID: 26475425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies.
    Clark HR; Ng TW; Khan A; Happe S; Dashe J; Xi Y; Twickler DM
    AJR Am J Roentgenol; 2020 Jun; 214(6):1417-1423. PubMed ID: 32208011
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 58. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta.
    Ghaghada KB; Starosolski ZA; Bhayana S; Stupin I; Patel CV; Bhavane RC; Gao H; Bednov A; Yallampalli C; Belfort M; George V; Annapragada AV
    Placenta; 2017 Sep; 57():60-70. PubMed ID: 28864020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Placental magnetic resonance imaging T2* measurements in normal pregnancies and in those complicated by fetal growth restriction.
    Sinding M; Peters DA; Frøkjaer JB; Christiansen OB; Petersen A; Uldbjerg N; Sørensen A
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):748-54. PubMed ID: 26041014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced T2*-weighted placental MRI predicts foetal growth restriction in women with chronic rheumatic disease-a Danish explorative study.
    Vestergaard T; Julsgaard M; Helmig RB; Faunø E; Vendelboe T; Kelsen J; Laurberg TB; Sørensen A; Pedersen BG
    Clin Rheumatol; 2024 Jun; 43(6):1989-1997. PubMed ID: 38671260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.